Extracorporeal immunoadsorption from whole blood based on the avidin-biotin concept. Evaluation of a new method

Michael Garkavij, Jan Tennvall, Sven-Erik Strand, Rune Nilsson, Lars Lindgren, Jangin Chen, Martin Isaksson, Håkan Eriksson, Hans-Olof Sjögren

Research output: Contribution to journalArticlepeer-review

Abstract

This study of 36 rats with rat colon adenocarcinoma transplants was carried out to investigate the efficacy of a new method of whole blood immunoadsorption (WBIA) in removing biotinylated monoclonal antibodies (MAbs) directly from unseparated blood, in order to increase 'the tumor/normal-tissue uptake ratio', as compared with extracorporeal immunoadsorption (ECIA) of antibodies from plasma. Compared with the ECIA system, the overall volume of the WBIA system (comprising only a pump, an adsorption column, a drop-chamber and tubings) was less (3.6 vs. 6.2 ml), and procedure duration 2 h less. The 17 rats undergoing the WBIA procedure, started 12 h after i.v. injection of 4.0-4.5 MBq 125I-BR96-biotin, manifested neither hemolysis nor any other complication; no signs of organ edema were found at dissection; whole body and blood radioactivity values were reduced by 51% and 89.5%, respectively. The WBIA method was as effective as ECIA, but technically simpler, safer and more reliable.
Original languageEnglish
Pages (from-to)309-312
JournalActa Oncologica
Volume35
Issue number3
DOIs
Publication statusPublished - 1996

Subject classification (UKÄ)

  • Cancer and Oncology

Fingerprint

Dive into the research topics of 'Extracorporeal immunoadsorption from whole blood based on the avidin-biotin concept. Evaluation of a new method'. Together they form a unique fingerprint.

Cite this